In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species
- 1 April 1999
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 33 (4) , 261-265
- https://doi.org/10.1016/s0732-8893(98)00150-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria.Journal of Antimicrobial Chemotherapy, 1997
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- From fluoroquinolones to 2-pyridonesThe Lancet, 1995
- In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniaeJournal of Antimicrobial Chemotherapy, 1994
- Microbial Etiology of Acute Pneumonia in Hospitalized PatientsChest, 1992
- In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella sppJournal of Antimicrobial Chemotherapy, 1992
- New and Emerging Etiologies for Community-Acquired Pneumonia with Implications for TherapyMedicine, 1990
- In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.Diagnostic Microbiology and Infectious Disease, 1989
- Prevalence of legionellosis among adults: A study of community-acquired pneumonia in FranceInfection, 1987
- Legionnairesʼ DiseaseMedicine, 1980